CYNTHIA JONES: Open Payments
NPI 1891087177 · CHATSWORTH, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,101 in 56 payments from 18 companies in 2025. Trend: 2023 $1,802 · 2024 $930 · 2025 $1,101
Food & beverage: $1,101
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $192 |
| Novo Nordisk Inc | 10 | $187 |
| Lilly USA, LLC | 6 | $112 |
| PFIZER INC. | 5 | $99 |
| Amneal Pharmaceuticals LLC | 4 | $95 |
| Axsome Therapeutics, Inc. | 3 | $68 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $68 |
| SHIELD THERAPEUTICS INC | 2 | $44 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $44 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $29 |
Products named: VRAYLAR, UNITHROID, Ozempic, ELIQUIS, Wegovy, MOUNJARO, Auvelity, CAPLYTA.
Industry payments across GA — which companies pay providers there.
